---
layout: archive

permalink: /cv/
author_profile: true
redirect_from:
  - /resume
---

{% include base_path %}

Education
======
* Master of Clinical Pharmacology, King’s College London, Sep 2022 - Sep 2023
  * Main courses: Good Clinical Practice, Data Management, Pharmaceutics, Pharmacokinetics and Pharmacodynamics
* Bachelor of Pharmacy, China Pharmaceutical University, Mar 2019 - Jan 2022
  * Main courses: Physiology, Pathophysiology, Biochemistry, Microbiology, Natural Pharmacochemistry, Medicinal Chemistry, Pharmaceutical Analysis, Pharmacology, Pharmacy

Work Experience
======
* Pharmacist, Wuxi Maternity and Child Healthcare Hospital, Wuxi, China, Jul 2018 - Present
  * Currently serving as a Clinical Trial Quality Assurance Officer at the hospital’s Drug Clinical Trial Center
  * Managed therapeutic drug monitoring and participated in multiple pharmacogenomic clinical intervention trials
* Secretary, Pharmaceutical Policy Professional Committee of Wuxi Pharmacists Association, Wuxi, China, Oct 2023 - Present
  * Coordinate drug policy meetings and handle policy recommendations from pharmacy experts to the government health departments

Projects
======
* Development of high-sensitivity EpCAM and MUC-1 Aptasensor for early diagnosis of breast cancer based on Carboxylic MXene, May 2023 – Aug 2023
  * Master’s Thesis
  * Systematically optimized critical parameters to enhance the sensitivity of the Aptasensor for the detection of EpCAM proteins and exosomes
  * The aptasensor demonstrated a large detection range and a low limit of detection
* Utilization of MTHFR Genetic Polymorphism Screening for Tailored Folic Acid Supplementation Strategies in Pregnant Women, Jul 2020 – Nov 2024
  * Hospital Research Topic
  * Utilized genetic polymorphism testing to stratify the risk of neural tube defects in infants
  * Ensured adequate doses of folate through personalized active folate supplementation and lifestyle guidance
  * Independently developed a results query system and secured two invention patents in collaboration with colleagues
* Investigation into the Polymorphism of the ESR1 Gene as a Predictive Marker for Osteoporosis in Breast Cancer Patients Undergoing Prolonged Therapy with Third-Generation Aromatase Inhibitors, Mar 2020 – Sep 2023
  * Hospital Research Topic
  * Examined the estrogen receptor (ESR1) gene polymorphisms in breast cancer patients
  * Collaborated with physicians and nutritionists to stratify patients based on their ESR1 genetic polymorphisms
  * Reduced the risk of osteoporosis in more than 200 postmenopausal breast cancer patients undergoing tamoxifen treatment

Qualifications
======
* Certificate Licensed Pharmacist, Nov 2021 – Present
* Certificate Good Clinical Practice, Oct 2023 – Present

Awards
======
* The First Prize of The 5th Hospital Quality Control Circle Competition, Jiangsu Province Hospital Association, 30/08/2021
* The Bronze Prize of Results Reporting Conference on Pharmaceutical Quality Management Activities in Jiangsu Provincial Hospitals, Jiangsu Pharmaceutical Association, 14/11/2020
* The Third Prize of The 2nd Medicine And Health Science China Tour, Southern Region, Chinese Pharmacists Association and China Health Promotion Foundation, 25/09/2020
* The First Prize of Results Reporting Conference on Pharmaceutical Quality Management Activities in Wuxi Hospitals, Wuxi Pharmaceutical Association, 16/09/2020

Patents
======
* Sample pretreatment device for folate gene and folate concentration determination, CN212988971U
* Cryogenic sample bottle, CN215063055U

Abilities
======
* Laboratory skills: HPLC, Flow cytometry, PCR, Electrochemical sensor development
* Programming: Origin, LaTeX, Markdown, Github, R
* Communication: Chinese (Native), English (C1)

